Skip to content

Clinical trials

Observational Alzheimer Disease trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Observational Country / region: Switzerland Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20162
20173
20202
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amoneta Diagnostics SAS2
University Hospital, Basel, Switzerland2
Andreas Monsch1
Boston Scientific Corporation1
Cantonal Hospital of St. Gallen1
University Hospital, Grenoble1
University of Bern1
University of Edinburgh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease10
Cognitive Dysfunction3
Frontotemporal Dementia2
Aneurysm1
Brain Neoplasms1
Cognition Disorders1
Corticobasal Degeneration1
Dementia1
Frontotemporal Lobar Degeneration1
Hypersensitivity1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.